ArticlePharmaceuticals (Basel, Switzerland)2021

Anti-Proliferative, Anti-Angiogenic and Safety Profiles of Novel HDAC Inhibitors for the Treatment of Metastatic Castration-Resistant Prostate Cancer.

Zohaib Rana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.